Skip to main content
. 2023 Nov 3;102(44):e35865. doi: 10.1097/MD.0000000000035865

Figure 2.

Figure 2.

Patients antibodies reacted with Mammalian cells transfected with contactin-associated protein-like 2 (CASPR2) (A) and leucine-rich glioma-inactivated 1 (LGI1) (B). Diluted serum samples (1:10) were collected on August 5th, 2021. Reacted with mammalian cells with CASPR2 and LGI1 on August 7th, 2021. Scale bars, 10 μm (A) and (B).